Standardizing febrile neutropenia management

Antimicrobial stewardship in the hematologic malignancy population

John C. O'Horo, Jasmine R Marcelin, Omar M.Abu Saleh, Amelia K. Barwise, Patricia M. Odean, Christina G. Rivera, Aaron J. Tande, John W. Wilson, Douglas R. Osmon, Pritish K. Tosh

Research output: Contribution to journalArticle

Abstract

Patients with febrile neutropenia (FN) often are subject to antibiotic and diagnostic test overuse. We sought to improve appropriate use of antimicrobials and diagnostic tests for patients with FN. We used a blended quality approach with Lean Six Sigma tools and iterative improvement of a clinical decision aid to guide providers through empirical antimicrobial selection and diagnostic evaluation of patients with FN during a yearlong period. We evaluated the incidence of nonadherence to best practice before, during, and after rollout of a clinical decision aid in conjunction with an educational initiative. At baseline, 71% of patients with FN had at least one critical deviation from best practice. During the project, the percentage decreased to 27.3%; 4 months after the project was completed, the percentage was 33.3% (P =.04). A clinical decision aid can improve adherence to best practices for the empirical management of FN.

Original languageEnglish (US)
Pages (from-to)E843-E848
JournalJournal of oncology practice
Volume15
Issue number9
DOIs
StatePublished - Jan 1 2019

Fingerprint

Febrile Neutropenia
Hematologic Neoplasms
Decision Support Techniques
Practice Guidelines
Population
Routine Diagnostic Tests
Total Quality Management
Practice Management
Anti-Bacterial Agents
Incidence

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy

Cite this

Standardizing febrile neutropenia management : Antimicrobial stewardship in the hematologic malignancy population. / O'Horo, John C.; Marcelin, Jasmine R; Saleh, Omar M.Abu; Barwise, Amelia K.; Odean, Patricia M.; Rivera, Christina G.; Tande, Aaron J.; Wilson, John W.; Osmon, Douglas R.; Tosh, Pritish K.

In: Journal of oncology practice, Vol. 15, No. 9, 01.01.2019, p. E843-E848.

Research output: Contribution to journalArticle

O'Horo, JC, Marcelin, JR, Saleh, OMA, Barwise, AK, Odean, PM, Rivera, CG, Tande, AJ, Wilson, JW, Osmon, DR & Tosh, PK 2019, 'Standardizing febrile neutropenia management: Antimicrobial stewardship in the hematologic malignancy population', Journal of oncology practice, vol. 15, no. 9, pp. E843-E848. https://doi.org/10.1200/JOP.18.00775
O'Horo, John C. ; Marcelin, Jasmine R ; Saleh, Omar M.Abu ; Barwise, Amelia K. ; Odean, Patricia M. ; Rivera, Christina G. ; Tande, Aaron J. ; Wilson, John W. ; Osmon, Douglas R. ; Tosh, Pritish K. / Standardizing febrile neutropenia management : Antimicrobial stewardship in the hematologic malignancy population. In: Journal of oncology practice. 2019 ; Vol. 15, No. 9. pp. E843-E848.
@article{9ee4b12f5144458eaa630394defa870a,
title = "Standardizing febrile neutropenia management: Antimicrobial stewardship in the hematologic malignancy population",
abstract = "Patients with febrile neutropenia (FN) often are subject to antibiotic and diagnostic test overuse. We sought to improve appropriate use of antimicrobials and diagnostic tests for patients with FN. We used a blended quality approach with Lean Six Sigma tools and iterative improvement of a clinical decision aid to guide providers through empirical antimicrobial selection and diagnostic evaluation of patients with FN during a yearlong period. We evaluated the incidence of nonadherence to best practice before, during, and after rollout of a clinical decision aid in conjunction with an educational initiative. At baseline, 71{\%} of patients with FN had at least one critical deviation from best practice. During the project, the percentage decreased to 27.3{\%}; 4 months after the project was completed, the percentage was 33.3{\%} (P =.04). A clinical decision aid can improve adherence to best practices for the empirical management of FN.",
author = "O'Horo, {John C.} and Marcelin, {Jasmine R} and Saleh, {Omar M.Abu} and Barwise, {Amelia K.} and Odean, {Patricia M.} and Rivera, {Christina G.} and Tande, {Aaron J.} and Wilson, {John W.} and Osmon, {Douglas R.} and Tosh, {Pritish K.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1200/JOP.18.00775",
language = "English (US)",
volume = "15",
pages = "E843--E848",
journal = "Journal of Oncology Practice",
issn = "1554-7477",
publisher = "American Society of Clinical Oncology",
number = "9",

}

TY - JOUR

T1 - Standardizing febrile neutropenia management

T2 - Antimicrobial stewardship in the hematologic malignancy population

AU - O'Horo, John C.

AU - Marcelin, Jasmine R

AU - Saleh, Omar M.Abu

AU - Barwise, Amelia K.

AU - Odean, Patricia M.

AU - Rivera, Christina G.

AU - Tande, Aaron J.

AU - Wilson, John W.

AU - Osmon, Douglas R.

AU - Tosh, Pritish K.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Patients with febrile neutropenia (FN) often are subject to antibiotic and diagnostic test overuse. We sought to improve appropriate use of antimicrobials and diagnostic tests for patients with FN. We used a blended quality approach with Lean Six Sigma tools and iterative improvement of a clinical decision aid to guide providers through empirical antimicrobial selection and diagnostic evaluation of patients with FN during a yearlong period. We evaluated the incidence of nonadherence to best practice before, during, and after rollout of a clinical decision aid in conjunction with an educational initiative. At baseline, 71% of patients with FN had at least one critical deviation from best practice. During the project, the percentage decreased to 27.3%; 4 months after the project was completed, the percentage was 33.3% (P =.04). A clinical decision aid can improve adherence to best practices for the empirical management of FN.

AB - Patients with febrile neutropenia (FN) often are subject to antibiotic and diagnostic test overuse. We sought to improve appropriate use of antimicrobials and diagnostic tests for patients with FN. We used a blended quality approach with Lean Six Sigma tools and iterative improvement of a clinical decision aid to guide providers through empirical antimicrobial selection and diagnostic evaluation of patients with FN during a yearlong period. We evaluated the incidence of nonadherence to best practice before, during, and after rollout of a clinical decision aid in conjunction with an educational initiative. At baseline, 71% of patients with FN had at least one critical deviation from best practice. During the project, the percentage decreased to 27.3%; 4 months after the project was completed, the percentage was 33.3% (P =.04). A clinical decision aid can improve adherence to best practices for the empirical management of FN.

UR - http://www.scopus.com/inward/record.url?scp=85072133021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072133021&partnerID=8YFLogxK

U2 - 10.1200/JOP.18.00775

DO - 10.1200/JOP.18.00775

M3 - Article

VL - 15

SP - E843-E848

JO - Journal of Oncology Practice

JF - Journal of Oncology Practice

SN - 1554-7477

IS - 9

ER -